Literature DB >> 15354260

Molecular mechanisms of megakaryocyte differentiation.

Harald Schulze1, Ramesh A Shivdasani.   

Abstract

Each bone marrow megakaryocyte (MK) releases thousands of platelets into the circulation, and the underlying molecular and cellular mechanisms recently have received intense scrutiny. Genetic studies are beginning to clarify the mechanisms by which transcription factors help distinguish MK progenitors from other blood cell lineages and subsequently confer unique cellular properties. Other investigations demonstrate that platelets are assembled de novo during a terminal phase of MK differentiation in which the cell extends cytoplasmic projections known as proplatelets. This review focuses on the roles of selected transcription factors with key roles in MK differentiation, and on human and murine models of thrombocytopenia that result from impaired MK differentiation. The findings we review help construct a framework to appreciate thrombopoietic mechanisms in the context of underlying lineage and morphologic transitions. Many of these mechanisms are unique to MKs but appear to rely both on genes that are expressed only in that lineage and others that are expressed widely.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15354260     DOI: 10.1055/s-2004-833474

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  10 in total

1.  Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.

Authors:  Hao G Nguyen; Guangyao Yu; Maria Makitalo; Dan Yang; Hou-Xiang Xie; Matthew R Jones; Katya Ravid
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

2.  Mechanisms of organelle transport and capture along proplatelets during platelet production.

Authors:  Jennifer L Richardson; Ramesh A Shivdasani; Chad Boers; John H Hartwig; Joseph E Italiano
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 3.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Integrated micro/messenger RNA regulatory networks in essential thrombocytosis.

Authors:  Lu Zhao; Song Wu; Erya Huang; Dimitri Gnatenko; Wadie F Bahou; Wei Zhu
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

5.  Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2.

Authors:  Zhao Chen; Michael Hu; Ramesh A Shivdasani
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

6.  Class prediction models of thrombocytosis using genetic biomarkers.

Authors:  Dmitri V Gnatenko; Wei Zhu; Xiao Xu; Edward T Samuel; Melissa Monaghan; Mohammad H Zarrabi; Christi Kim; Anil Dhundale; Wadie F Bahou
Journal:  Blood       Date:  2009-09-22       Impact factor: 22.113

7.  In vivo inactivation of MASTL kinase results in thrombocytopenia.

Authors:  H Jan Johnson; Manish J Gandhi; Ebrahim Shafizadeh; Nathaniel B Langer; Eric L Pierce; Barry H Paw; Diana M Gilligan; Jonathan G Drachman
Journal:  Exp Hematol       Date:  2009-05-19       Impact factor: 3.084

Review 8.  Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application.

Authors:  Naoya Takayama; Koji Eto
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

9.  Replication of Dengue Virus in K562-Megakaryocytes Induces Suppression in the Accumulation of Reactive Oxygen Species.

Authors:  Jaskaran Kaur; Yogita Rawat; Vikas Sood; Neha Periwal; Deepak Kumar Rathore; Shrikant Kumar; Niraj Kumar; Sankar Bhattacharyya
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

10.  A systems-biology analysis of isogenic megakaryocytic and granulocytic cultures identifies new molecular components of megakaryocytic apoptosis.

Authors:  Chi Chen; Peter G Fuhrken; Li Ting Huang; Pani Apostolidis; Min Wang; Carlos J Paredes; William M Miller; Eleftherios T Papoutsakis
Journal:  BMC Genomics       Date:  2007-10-22       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.